Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil vs Provigil in Chronic Shift Work Sleep Disorder
NCT00236080Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of armodafinil in shift work sleep disorder (SWSD), sponsored by Cephalon, Inc.. Started Aug 2005; status: completed.
02
Drugs
armodafinil
03
Conditions
shift work sleep disorder (SWSD)
Beyond the preview
Go deeper on NCT00236080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236080.